I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 41 studies | 49% ± 19% | |
| macrophage | 37 studies | 43% ± 17% | |
| conventional dendritic cell | 27 studies | 48% ± 16% | |
| dendritic cell | 25 studies | 60% ± 25% | |
| non-classical monocyte | 23 studies | 46% ± 18% | |
| classical monocyte | 22 studies | 35% ± 14% | |
| monocyte | 20 studies | 42% ± 18% | |
| naive B cell | 20 studies | 57% ± 20% | |
| memory B cell | 19 studies | 56% ± 20% | |
| mast cell | 18 studies | 37% ± 16% | |
| plasmacytoid dendritic cell | 14 studies | 34% ± 18% | |
| myeloid cell | 11 studies | 52% ± 19% | |
| alveolar macrophage | 8 studies | 35% ± 9% | |
| neutrophil | 8 studies | 32% ± 18% | |
| microglial cell | 8 studies | 42% ± 25% | |
| natural killer cell | 7 studies | 23% ± 5% | |
| leukocyte | 7 studies | 41% ± 13% | |
| mononuclear phagocyte | 6 studies | 50% ± 23% | |
| immature B cell | 6 studies | 47% ± 13% | |
| monocyte-derived dendritic cell | 5 studies | 74% ± 17% | |
| endothelial cell | 5 studies | 32% ± 13% | |
| precursor B cell | 5 studies | 37% ± 24% | |
| innate lymphoid cell | 5 studies | 34% ± 12% | |
| mucosal invariant T cell | 4 studies | 24% ± 5% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 26% ± 10% | |
| germinal center B cell | 4 studies | 42% ± 17% | |
| intermediate monocyte | 4 studies | 40% ± 16% | |
| plasmablast | 3 studies | 19% ± 2% | |
| gamma-delta T cell | 3 studies | 23% ± 5% | |
| regulatory T cell | 3 studies | 20% ± 4% |
